Normal function · from ai-gene-review (P49810, commit 79fe13b38970) · AI-generated, not KB evidence

Presenilin-2 is a multi-pass membrane aspartyl protease subunit of gamma-secretase complexes. After endoproteolytic maturation, PSEN2 N- and C-terminal fragments assemble with nicastrin, APH1, and PEN2 to cleave type I membrane-protein substrates, including APP-derived C-terminal fragments and Notch receptor substrates. PSEN2-containing complexes are distinguished from PSEN1 complexes by stronger late endosome/lysosome enrichment mediated by an AP-1-dependent N-terminal sorting motif, which shapes substrate access and intracellular amyloid-beta generation. Additional evidence links PSEN2 to endoplasmic-reticulum/mitochondrial calcium coupling and membrane-contact site biology, but these activities are secondary to its gamma-secretase catalytic role.

PSEN2 is a catalytic presenilin isoform in mature gamma-secretase complexes. It cleaves membrane-protein substrates including APP-derived C-terminal fragments and Notch receptor substrates, with PSEN2 complexes showing prominent late endosome/lysosome enrichment that shapes substrate specificity and intracellular amyloid-beta generation.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Dilated Cardiomyopathy 1V unknown germline
mechanism: PSEN2 Ser130Leu Missense Variant in Cardiomyocytes
animal model: Presenilin-2 knockout mouse (cardiac phenotype)
Early-Onset Autosomal Dominant Alzheimer Disease causative germline
mechanism: Pathogenic APP, PSEN1, or PSEN2 Germline Variant
subtype: PSEN2
scoped to subtype: PSEN2
Alzheimer Disease untyped
Genetic Mutation
mechanism: Amyloid Plaque Formation
scoped to subtype: Early-Onset Alzheimer's Disease
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
dilated cardiomyopathy 1V MONDO:0013373 AD Limited
2026-03-04
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.